Clinical Trials
129 trialsROR
Abramson Cancer Center at Penn Medicine
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Self-management Interventions to Reduce Cardiovascular Risks in Breast Cancer Survivors
University of Southern Queensland
HAPIN
Emory University
HER-CROWN
Ottawa Heart Institute Research Corporation
Cancer and Blood Pressure Management, CARISMA Study
Eastern Cooperative Oncology Group
Physical Capacity in Hodgkin Lymphoma Survivors
University of Sao Paulo General Hospital
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
University of Michigan Rogel Cancer Center
AH-HA
Wake Forest University Health Sciences
GRACE
Duke University
GC-PRO Intervention
University of Minnesota
BEAMER
Technical University of Madrid
HEALTHY-AYA
Duke University
RISP
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PULSE
Dana-Farber Cancer Institute
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Peking Union Medical College Hospital
Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone Therapy
University of Oran 1
ONE TEAM
Duke University
ALDH2 Genetic Testing in East Asian Community
Northwestern University
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Home-Based Measures of Physical Activity and Body Composition
M.D. Anderson Cancer Center
COUNTS2
University of California, San Francisco
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
Pfizer
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
Roswell Park Cancer Institute
HYDRA
Leiden University Medical Center
Strive Cardio for Endometrial Cancer Survivors
University of Iowa
WB2020
Colorado State University
VITAL
Brigham and Women's Hospital
ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors
University of Massachusetts, Worcester
COSMOS
Brigham and Women's Hospital
CHURCH
Columbia University
ARQ 531-101
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
IMPACT-Women
University of Alberta
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
Western University
CV CARE: CardioVascular Care in PC Patients
Dana-Farber Cancer Institute
ALLSTAR
Abramson Cancer Center at Penn Medicine
TRIABETES
University of Pittsburgh
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
MoveStrong
University of Waterloo
CRIBCO
University of Michigan Rogel Cancer Center
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
PCOS
University of Alberta
RADICALPC
McMaster University
UNATI
Clinica Universidad de Navarra, Universidad de Navarra
Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health
American College of Radiology
POLARIC-13
National Heart Centre Singapore
STAREE
Monash University
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
Shenzhen University General Hospital
Survivor mHealth: Wearable Devices in Cancer Survivors
University of Massachusetts, Worcester
Study of Clinic-delivered Physical Activity Referrals to Cancer Survivors
University of Massachusetts, Worcester